CCKBR and adenocarcinoma: It has been well-recognized that both the expression of CCK2R and CCK1R are increased in numerous human NETs over the corresponding normal tissues, suggesting that both receptors might be utilized as molecular targets for localization of certain adenocarcinomas by radiopeptide imaging in vivo, and more recently, for treatment by peptide receptor radiation therapy (168, 169).